|
air jordan 11 Low IE True Redわたなべ2015年9月3日 Novavax also has adjuvant technology, which is known as Matrix technology. Under this, the company develops vaccine adjuvants which are used as additional components in vaccines to strengthen the immune response and prolong the effects of the vaccine. This technology is being used in various vaccines in the veterinary vaccine market, such as in Equilis Prequenza for horses. The most advanced candidate for seasonal influenza is in phase III of clinical trials, which is being developed under the CPLB collaboration. CPLB is also developing a rabies vaccine, and is in phase II. The combination respiratory vaccine is in preclinical stage, whereas the ebola virus candidate is in phase I of development. A number of other candidates of Novavax are also being developed under collaborations, thus offsetting the need for large R expenditure. [参考] |
コメントはありません |